The summit will highlight our country’s unique resources and capabilities, and showcase some of the current developments in the cell, gene and tissue-engineered therapy domains, as well as with key enabling technologies and manufacturing infrastructure. The major challenges faced by developers of advanced therapies will also be highlighted, drawing on experience of other ATMP hubs in Europe, as to how gaps may be addressed in the Belgian ecosystem, sometimes cited as being too fragmented to fully realize the country’s potential.
With speakers from within Belgium and across Europe, the summit will bring together an audience of over 250 public and private stakeholders –
medicine and academia, industry, government and regulators, as well as patient representatives – in what is expected to be a major event in the 2023 calendar.
On October 19th you are welcome to join us in Leuven for a program packed with interesting speakers out of both industry and academia.
Tickets are 400 euro for non members and 150 euro for academia, but as at.las is part of the organizing committee, our non-academic members enjoy an additional discount and can join for 250 euro. What are you waiting for?
How to register?
Find the entire program and registration form here.
